HCG.BO(HCG.BO)
HCG.BO
No analyst ratings available
No analyst price targets available for HCG.BO
Analyst coverage may not be available for this symbol
No recent analyst actions
| Metric | FY2027E | FY2028E |
|---|---|---|
| Revenue Avg | $29.57B | $33.98B |
| Low | $28.87B | $32.95B |
| High | $30.58B | $35.15B |
| EBITDA Avg | $6.39B | $7.34B |
| Low | $6.24B | $7.12B |
| High | $6.61B | $7.60B |
| EBIT Avg | $5.66B | $6.50B |
| Low | $5.52B | $6.30B |
| High | $5.85B | $6.73B |
| Net Income Avg | $1.35B | $2.22B |
| Low | $950M | $1.55B |
| High | $2.33B | $3.23B |
| EPS Avg | $11.51 | $18.71 |
| Low | $6.72 | $10.93 |
| High | $16.49 | $22.81 |
| Analysts (Rev / EPS) | 9 / 8 | 9 / 8 |
| Metric | Q3 2026 | Q4 2026 | Q1 2027 |
|---|---|---|---|
| Revenue Avg | $7.54B | $7.64B | $7.60B |
| Low | $7.54B | $7.64B | $7.60B |
| High | $7.54B | $7.64B | $7.60B |
| EBITDA Avg | $1.68B | $1.70B | $1.69B |
| Low | $1.68B | $1.70B | $1.69B |
| High | $1.68B | $1.70B | $1.69B |
| EBIT Avg | $775M | $786M | $782M |
| Low | $775M | $786M | $782M |
| High | $775M | $786M | $782M |
| Net Income Avg | $476M | $395M | $615M |
| Low | $476M | $395M | $615M |
| High | $476M | $395M | $615M |
| EPS Avg | $3.29 | $2.73 | $4.25 |
| Low | $3.29 | $2.73 | $4.25 |
| High | $3.29 | $2.73 | $4.25 |
| Analysts (Rev / EPS) | 1 / 1 | 1 / 1 | 1 / 1 |